ArticleMolecular biology reports2025
A novel DNA aptamer for Vibrio cholerae O139 detection: a whole-cell SELEX approach.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVibrio cholerae O139 is a significant waterborne pathogen responsible for severe cholera outbreaks, particularly in regions with poor sanitation. Early and accurate detection of this strain is necessary to limit rapid disease spread and reduce mortality rates. Conventional detection methods are hindered by long processing times, high costs, and dependency on specialized equipment, thus limiting their usability in resource-poor settings. METHODS AND
resultsThis study employed a whole-cell Systematic Evolution of Ligands by EXponential enrichment (SELEX) process to isolate high-affinity DNA aptamers for V. cholerae O139. Twelve aptamer sequences were isolated after 12 SELEX rounds, two counter-selections against E. coli, and the best affinity and specificity were noted with the aptamer VcA7 by a low dissociation constant (Kd = 14.72 ± 0.89 pM) by flow cytometry protocols. In silico docking analysis indicated a high affinity of VcA7 to bind with the Outer membrane protein U (OmpU), a significant surface receptor of V. cholerae O139. Fluorescence microscopy and specificity assays identified the selective binding to the target pathogen without cross-reactivity with closely related bacterial pathogens, such as V. parahaemolyticus, E. coli, and S. aureus.
conclusionThe aptamer VcA7 displayed high affinity and specificity for V. cholerae O139, surpassing other contenders in both computational and experimental screening. Its high binding activity to OmpU, combined with its high selectivity, render VcA7 a valuable biorecognition element for aptamer-based diagnostic tools. This research helps in the design of rapid, affordable, and field-deployable diagnostic kits for cholera surveillance in resource-poor countries and endemic environments.
Indexed as
Identifiers
40488973What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.